(1 - 14 von 16
)
Sanofi finalizes Praluent® (alirocumab) restructuring with Regeneron
edition.cnn.com
View market sector performance relative to the S&P 500 Index and trended stock performance over time.
Investegate |Sanofi Aventis Announcements | Sanofi Aventis:...
investegate.co.uk
Investegate announcements from Sanofi Aventis, Sanofi-aventis Successfully Completes the Acqui...
Nuevo estudio explica el papel de la Terapia Dual antitrombocitos en...
www.europapress.es
[TAB] Referencias: Datos de archivo, sanofi-aventis Información de...
Neue Studie erweitert das Verständnis der Rolle einer...
www.ots.at
- Gewissen Untergruppen profitieren möglicherweise von einer dualen Therapie, bei anderen sollte diese vermieden werden -
Sanofi to evaluate the safety and efficacy of novel ...
www.finanznachrichten.de
Sanofi Investor Relations Contacts Paris Eva Schaefer-Jansen Arnaud Delepine Yvonne Naughton Sanofi Investor Relations Contacts North America Felix Lauscher …
Alzheimer's Association
act.alz.org
Irwin & Carol Miller - $ Dina Chaiffetz - $ Liza Scullin - $ Candice Rosenson - $ Felix Lauscher - $ Irina Ivanova - $
Press Release: Strong sales and business EPS growth ...
www.wallstreet-online.de
Feb 04, · Felix Lauscher | + | Priya Nanduri | + | Nathalie Pham | + |
finanzen.net - Seite nicht gefunden
www.finanzen.net
Sanofi offers to acquire Kiadis, a clinical-stage company developing cell-based immunotherapy products | Nachricht | finanzen.net
Sanofi SA (NASDAQ: SNY) - AlphaStreetnews.alphastreet.com › symbol › sny
news.alphastreet.com
Sanofi SA (SNY) Q earnings call dated Feb. 06, Corporate Participants: Felix Lauscher -- Head of Investor Relations Paul Hudson -- Chief ...
Sanofi : Filing of the U.S. Form 20-F and French “Document...www.marketscreener.com › France › Sanofi › News
www.marketscreener.com
· Felix Lauscher Fara Berkowitz Suzanne Greco IR main line: Tel.: +33 (0)
Sanofi is partnering with world-leading academic cooperative ...www.bigagainstbreastcancer.org › news › sanofi-par...
www.bigagainstbreastcancer.org
· Felix Lauscher Fara Berkowitz Suzanne Greco Sanofi IR main line: Tel: +33 (0)
sortiert nach Relevanz / Datum